What is the market doing?
What the tape says about ALVO
Alvotech is −42% over the past year while the S&P 500 is +20%: 62 points behind the market.
−42%
1-year return · S&P 500 +20%
- vs 200-day average
- +22%
vs 200-day average · a clear uptrend
- RSI (14)
- 78
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- 42%
Below its 52-week high
Details›
- Last close2026-09-08
- $5.21
- 1 monthS&P 500 −0.30%
- +37%
- 1 yearS&P 500 +20%
- −42%
- vs 50-day average$4.02
- +30%
- 52-week high
- $8.98
- 52-week low
- $3.00
- Annualised volatility
- 64%
| Year | Return |
|---|---|
| 2026 (year to date) | +1.6% |
| 2025 | −61% |
| 2024 | +15% |
| 2023 | +15% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 3 of 4 | +15% |
| Feb | 4 | 1 of 4 | −5.8% |
| Mar | 4 | 0 of 4 | −14% |
| Apr | 4 | 1 of 4 | −6.7% |
| May | 4 | 2 of 4 | +7.1% |
| Jun | 4 | 1 of 4 | −9.3% |
| Jul | 5 | 1 of 5 | +1.7% |
| Aug | 5 | 3 of 5 | +14% |
| Sep | 5 | 3 of 5 | −5.8% |
| Oct | 4 | 1 of 4 | −2.1% |
| Nov | 4 | 2 of 4 | −8.6% |
| Dec | 4 | 4 of 4 | +23% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #15 of 29 by Smart Score